
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $128.8M | -- | -- | $0.17 | -- |
08/08/2025 | Q2 | $122.1M | -- | -- | $0.14 | -- |
05/07/2025 | Q1 | $118.7M | $114.8M | $0.11 | -- | -- |
03/03/2025 | Q4 | $112.8M | $117.5M | $0.46 | $0.15 | $0.31 |
11/07/2024 | Q3 | $105.9M | $119.8M | $0.15 | $0.13 | $0.02 |
08/08/2024 | Q2 | $86.4M | $107.2M | $0.13 | $0.08 | $0.05 |
05/09/2024 | Q1 | $77.3M | $81.9M | $0.08 | $0.05 | $0.03 |
02/28/2024 | Q4 | $73M | $73.9M | -$0.08 | $0.02 | -$0.10 |
11/08/2023 | Q3 | -- | -- | $0.01 | -$0.01 | $0.02 |
08/09/2023 | Q2 | -- | -- | -$0.03 | -$0.03 | -$0.00 |
05/10/2023 | Q1 | -- | -- | -$0.03 | -$0.04 | $0.01 |
03/23/2023 | Q4 | -- | -- | -$0.06 | -$0.07 | $0.01 |
11/09/2022 | Q3 | -- | -- | -$0.08 | -$0.07 | -$0.01 |
08/10/2022 | Q2 | -- | -- | -$0.07 | -$0.08 | $0.01 |
05/11/2022 | Q1 | -- | -- | -$0.13 | -$0.08 | -$0.05 |
03/24/2022 | Q4 | -- | -- | -$0.09 | -$0.09 | $0.00 |
11/10/2021 | Q3 | -- | -- | -$0.13 | -$0.14 | $0.01 |
08/11/2021 | Q2 | -- | -- | -$0.15 | -$0.16 | $0.01 |
05/12/2021 | Q1 | -- | -- | -$0.16 | -$0.17 | $0.01 |
03/25/2021 | Q4 | -- | -- | -$0.20 | -- | -- |
11/05/2020 | Q3 | -- | -- | -$0.19 | -- | -- |
08/05/2020 | Q2 | -- | -- | -$0.23 | -- | -- |
05/06/2020 | Q1 | -- | -- | -$0.26 | -- | -- |
03/12/2020 | Q4 | -- | -- | -$0.18 | -- | -- |
11/06/2019 | Q3 | -- | -- | -$0.19 | -- | -- |
08/08/2019 | Q2 | -- | -- | -$0.25 | -- | -- |
05/08/2019 | Q1 | -- | -- | -$0.28 | -- | -- |
03/13/2019 | Q4 | -- | -- | -$0.39 | -- | -- |
11/08/2018 | Q3 | -- | -- | -$0.33 | -- | -- |
08/10/2018 | Q2 | -- | -- | -$0.35 | -- | -- |
05/14/2018 | Q1 | -- | -- | -$0.39 | -- | -- |
03/05/2018 | Q4 | -- | -- | -$0.29 | -- | -- |
11/03/2017 | Q3 | -- | -- | -$0.59 | -- | -- |
08/11/2017 | Q2 | -- | -- | -$0.55 | -- | -- |
03/31/2017 | Q1 | -- | -- | -$0.51 | -- | -- |
02/24/2017 | Q4 | -- | -- | -$0.35 | -- | -- |
09/30/2016 | Q3 | -- | -- | -$0.34 | -- | -- |
06/30/2016 | Q2 | -- | -- | -$0.50 | -- | -- |
03/31/2016 | Q1 | -- | -- | -$0.43 | -- | -- |
12/31/2015 | Q4 | -- | -- | -$0.45 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$0.48 | -- | -- |
ADMA Biologics reported $114.8M worth of top line sales in its most recent quarter.
ADMA Biologics announced earnings per share of $0.11 which represents a beat of analyst forecast a -- per share.
ADMA Biologics reported $61.1M that represents $0.25 per share over the last quarter.
ADMA Biologics's earnings are forecast to decrease from $0.81 per share to $0.52 per share next year representing a decrease of -25.52%.
ADMA Biologics's next earnings date is August 8, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.